• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Age of natural menopause onset in carriers - systematic review and meta-analysis.携带者自然绝经开始的年龄——系统评价与荟萃分析
Prz Menopauzalny. 2020 Dec;19(4):171-173. doi: 10.5114/pm.2020.101946. Epub 2021 Jan 7.
2
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
3
Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.BRCA1 和 BRCA2 致病性变异携带者行卵巢和输卵管的专业肿瘤外科切除术,可能会将原发性腹膜癌风险降低至非常低的水平。
Int J Cancer. 2021 Mar 1;148(5):1155-1163. doi: 10.1002/ijc.33378. Epub 2020 Nov 11.
4
Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.BRCA1 和 BRCA2 基因突变携带者的自然绝经年龄是否早于其非携带者亲属?来自 Kathleen Cuningham 基金会家族性乳腺癌研究联盟的研究结果。
J Clin Oncol. 2013 Nov 1;31(31):3920-5. doi: 10.1200/JCO.2013.49.3007. Epub 2013 Sep 30.
5
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.对BRCA1或BRCA2基因突变携带者行降低风险的输卵管卵巢切除术相关风险降低估计值的荟萃分析。
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442. Epub 2009 Jan 13.
6
Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.遗传性 BRCA 基因突变携带者的子宫内膜癌:系统评价和荟萃分析。
J Minim Invasive Gynecol. 2021 May;28(5):947-956. doi: 10.1016/j.jmig.2020.11.023. Epub 2020 Nov 27.
7
Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California.BRCA1/2 突变携带者与加利福尼亚北部非临床样本女性自然绝经年龄的比较。
Cancer. 2013 May 1;119(9):1652-9. doi: 10.1002/cncr.27952. Epub 2013 Jan 29.
8
Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.携带BRCA1和BRCA2致病变异者的计划生育
J Genet Couns. 2021 Dec;30(6):1570-1581. doi: 10.1002/jgc4.1423. Epub 2021 Apr 27.
9
Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.比较 40 岁以下被诊断患有乳腺癌的澳大利亚女性中 BRCA1 和 BRCA2 致病性突变携带者与非携带者常见遗传变异和单倍型的频率。
BMC Cancer. 2010 Sep 1;10:466. doi: 10.1186/1471-2407-10-466.
10
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.评估胚系 BRCA1 和 BRCA2 变异对葡萄膜和皮肤黑色素瘤的贡献。
Melanoma Res. 2019 Oct;29(5):483-490. doi: 10.1097/CMR.0000000000000613.

引用本文的文献

1
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients.中国客家乳腺癌患者的 BRCA1 和 BRCA2 种系突变。
BMC Med Genomics. 2024 Jan 2;17(1):3. doi: 10.1186/s12920-023-01772-9.
2
CA125 Levels in BRCA mutation carriers - a retrospective single center cohort study.BRCA 基因突变携带者的 CA125 水平 - 一项回顾性单中心队列研究。
BMC Cancer. 2023 Jul 1;23(1):610. doi: 10.1186/s12885-023-11116-6.
3
BRCA Mutations-The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers.BRCA 基因突变——乳腺癌、卵巢癌和其他上皮性癌症的阿喀琉斯之踵。
Int J Mol Sci. 2023 Mar 5;24(5):4982. doi: 10.3390/ijms24054982.

本文引用的文献

1
Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis.探讨评估 BRCA1/2 突变和卵巢功能标志物的文献:系统评价和荟萃分析。
J Assist Reprod Genet. 2020 May;37(5):1037-1055. doi: 10.1007/s10815-020-01745-2. Epub 2020 Mar 24.
2
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
3
Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women.BRCA种系突变女性的女性生育力和生殖寿命的潜在影响。
Arch Gynecol Obstet. 2016 Nov;294(5):1099-1103. doi: 10.1007/s00404-016-4187-6. Epub 2016 Aug 25.
4
The impact of FMR1 gene mutations on human reproduction and development: a systematic review.FMR1基因突变对人类生殖与发育的影响:一项系统综述
J Assist Reprod Genet. 2016 Sep;33(9):1135-47. doi: 10.1007/s10815-016-0765-6. Epub 2016 Jul 18.
5
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?携带BRCA1/2基因突变的人会更早自然绝经吗?
Menopause. 2016 Aug;23(8):903-10. doi: 10.1097/GME.0000000000000633.
6
FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patterns.以色列BRCA1/BRCA2突变携带者和普通人群中FMR1基因CGG等位基因长度呈现出不同的分布模式。
Genet Res (Camb). 2014 Oct 8;96:e11. doi: 10.1017/S0016672314000147.
7
Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.BRCA1 和 BRCA2 基因突变携带者的自然绝经年龄是否早于其非携带者亲属?来自 Kathleen Cuningham 基金会家族性乳腺癌研究联盟的研究结果。
J Clin Oncol. 2013 Nov 1;31(31):3920-5. doi: 10.1200/JCO.2013.49.3007. Epub 2013 Sep 30.
8
Association of BRCA1/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal age.BRCA1/2 基因突变与 FMR1 基因型的关联:对初潮和绝经年龄的影响。
Maturitas. 2013 Jun;75(2):148-51. doi: 10.1016/j.maturitas.2013.03.002. Epub 2013 Mar 23.
9
Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study.多民族人群基因与流行病学研究中遗传位点复制与初潮和绝经年龄的关联。
Hum Reprod. 2013 Jun;28(6):1695-706. doi: 10.1093/humrep/det071. Epub 2013 Mar 18.
10
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation.携带 BRCA1 或 BRCA2 突变的女性中早发性卵巢功能不全的频率。
Fertil Steril. 2013 May;99(6):1724-8. doi: 10.1016/j.fertnstert.2013.01.109. Epub 2013 Feb 13.

携带者自然绝经开始的年龄——系统评价与荟萃分析

Age of natural menopause onset in carriers - systematic review and meta-analysis.

作者信息

Kępczyński Łukasz, Połatyńska Katarzyna, Nykel Anna, Sałamunia Jordan, Kałużewski Tadeusz, Kużawczyk Andrzej, Gach Agnieszka

机构信息

Department of Genetics, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.

Department of Neurology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.

出版信息

Prz Menopauzalny. 2020 Dec;19(4):171-173. doi: 10.5114/pm.2020.101946. Epub 2021 Jan 7.

DOI:10.5114/pm.2020.101946
PMID:33488327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7812531/
Abstract

INTRODUCTION

Germinal pathogenic variants in and genes are associated with high risk of cancers, including breast, ovary, fallopian tubes and primary peritoneal. Non-oncological implications of germline pathogenic variants in and genes, complicating reproductive health are less described. The influence of and on age of natural menopause remains inconclusive and controversial.

MATERIAL AND METHODS

PubMed database was searched for potentially relevant abstracts. Studies which were not case-control, cohort or cross-sectional studies were subsequently excluded. Reference lists from systematic reviews or meta-analyses, dealing with the topic of menopause and and germinal pathogenic variants, were also checked to identify eligible studies. We also included our original, unpublished data from families, affected by or pathogenic variant, consisted of at least two postmenopausal female siblings with differing variant status.

RESULTS AND CONCLUSIONS

Initial database search retrieved 193 abstracts. We identified 4 eligible studies for meta-analysis. Two studies not reporting dispersion measures and not reporting age of natural menopause in control group were left in summary for illustrational purposes, yet were excluded from meta-analysis. 4 studies and our original, unpublished data, combining data from 1535 germinal and pathogenic variant carriers and 3191 control individuals, did not support the hypothesis of association between germinal pathogenic variants of "breast cancer genes" and premature menopause.

摘要

引言

BRCA1和BRCA2基因中的胚系致病性变异与包括乳腺癌、卵巢癌、输卵管癌和原发性腹膜癌在内的多种癌症的高风险相关。BRCA1和BRCA2基因胚系致病性变异对生殖健康造成的非肿瘤学影响鲜少被描述。BRCA1和BRCA2对自然绝经年龄的影响仍未定论且存在争议。

材料与方法

在PubMed数据库中搜索潜在相关摘要。随后排除非病例对照研究、队列研究或横断面研究。还查阅了关于绝经以及BRCA1和BRCA2胚系致病性变异主题的系统评价或荟萃分析的参考文献列表,以确定符合条件的研究。我们还纳入了来自受BRCA1或BRCA2致病性变异影响的家庭的原始未发表数据,这些家庭至少有两名绝经后女性兄弟姐妹,其变异状态不同。

结果与结论

初步数据库搜索检索到193篇摘要。我们确定了4项符合条件的研究进行荟萃分析。为了说明目的,两项未报告离散度测量且未报告对照组自然绝经年龄的研究被保留在综述中,但被排除在荟萃分析之外。4项研究以及我们的原始未发表数据,合并了1535名BRCA1和BRCA2胚系致病性变异携带者以及3191名对照个体的数据,不支持“乳腺癌基因”胚系致病性变异与过早绝经之间存在关联的假设。